These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25539143)

  • 1. LC-MS/MS improves screening towards 21-hydroxylase deficiency.
    Ambroziak U; Kępczyńska-Nyk A; Kuryłowicz A; Wysłouch-Cieszyńska A; Małunowicz EM; Bartoszewicz Z; Kondracka A; Jaźwiec R; Pawłowska E; Szcześniak M; Dadlez M; Bednarczuk T
    Gynecol Endocrinol; 2015 Apr; 31(4):296-300. PubMed ID: 25539143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnosis of nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, based on serum basal or post-ACTH stimulation 17-hydroxyprogesterone, can lead to false-positive diagnosis.
    Ambroziak U; Kępczyńska-Nyk A; Kuryłowicz A; Małunowicz EM; Wójcicka A; Miśkiewicz P; Macech M
    Clin Endocrinol (Oxf); 2016 Jan; 84(1):23-9. PubMed ID: 26331608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum 21-Deoxycortisol for Diagnosis of Nonclassic Congenital Adrenal Hyperplasia in Women With Androgen Excess.
    Ng JL; Lim EM; Zhang R; Beilby JP; Watts GF; Brown SJ; Stuckey BGA
    J Clin Endocrinol Metab; 2023 Nov; 108(12):e1560-e1570. PubMed ID: 37358001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid biomarkers for identifying non-classic adrenal hyperplasia due to 21-hydroxylase deficiency in a population of PCOS with suspicious levels of 17OH-progesterone.
    Oriolo C; Fanelli F; Castelli S; Mezzullo M; Altieri P; Corzani F; Pelusi C; Repaci A; Di Dalmazi G; Vicennati V; Baldazzi L; Menabò S; Dormi A; Nardi E; Brillanti G; Pasquali R; Pagotto U; Gambineri A
    J Endocrinol Invest; 2020 Oct; 43(10):1499-1509. PubMed ID: 32236851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LC-MS/MS based determination of basal- and ACTH-stimulated plasma concentrations of 11 steroid hormones: implications for detecting heterozygote CYP21A2 mutation carriers.
    Kulle AE; Riepe FG; Hedderich J; Sippell WG; Schmitz J; Niermeyer L; Holterhus PM
    Eur J Endocrinol; 2015 Oct; 173(4):517-24. PubMed ID: 26315375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenal steroid profiling as a diagnostic tool to differentiate polycystic ovary syndrome from nonclassic congenital adrenal hyperplasia: pinpointing easy screening possibilities and normal cutoff levels using liquid chromatography tandem mass spectrometry.
    Ueland GÅ; Dahl SR; Methlie P; Hessen S; Husebye ES; Thorsby PM
    Fertil Steril; 2022 Aug; 118(2):384-391. PubMed ID: 35725670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parallel diurnal fluctuation of testosterone, androstenedione, dehydroepiandrosterone and 17OHprogesterone as assessed in serum and saliva: validation of a novel liquid chromatography-tandem mass spectrometry method for salivary steroid profiling.
    Mezzullo M; Fazzini A; Gambineri A; Di Dalmazi G; Mazza R; Pelusi C; Vicennati V; Pasquali R; Pagotto U; Fanelli F
    Clin Chem Lab Med; 2017 Aug; 55(9):1315-1323. PubMed ID: 28076306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated, fast and sensitive quantification of 17 alpha-hydroxy-progesterone, androstenedione and testosterone by tandem mass spectrometry with on-line extraction.
    Rauh M; Gröschl M; Rascher W; Dörr HG
    Steroids; 2006 Jun; 71(6):450-8. PubMed ID: 16569417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for Nonclassic Congenital Adrenal Hyperplasia in the Era of Liquid Chromatography-Tandem Mass Spectrometry.
    Chesover AD; Millar H; Sepiashvili L; Adeli K; Palmert MR; Hamilton J
    J Endocr Soc; 2020 Feb; 4(2):bvz030. PubMed ID: 32110745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a total serum testosterone, androstenedione, 17-hydroxyprogesterone, 11β-hydroxyandrostenedione and 11-ketotestosterone LC-MS/MS assay and its application to evaluate pre-analytical sample stability.
    Hawley JM; Adaway JE; Owen LJ; Keevil BG
    Clin Chem Lab Med; 2020 Apr; 58(5):741-752. PubMed ID: 31926069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for non-classic congenital adrenal hyperplasia in women: New insights using different immunoassays.
    Nakhleh A; Saiegh L; Shehadeh N; Weintrob N; Sheikh-Ahmad M; Supino-Rosin L; Alboim S; Gendelman R; Zloczower M
    Front Endocrinol (Lausanne); 2022; 13():1048663. PubMed ID: 36704043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid monitoring assay of congenital adrenal hyperplasia with microbore high-performance liquid chromatography/electrospray ionization tandem mass spectrometry from dried blood spots.
    Lai CC; Tsai CH; Tsai FJ; Lee CC; Lin WD
    Rapid Commun Mass Spectrom; 2001; 15(22):2145-51. PubMed ID: 11746879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients.
    Ambroziak U; Kuryłowicz A; Kępczyńska-Nyk A; Bartoszewicz Z; Kondracka A; Jaźwiec R; Samborowska E; Dadlez M; Wysłouch-Cieszyńska A; Bednarczuk T
    Ginekol Pol; 2017; 88(1):5-8. PubMed ID: 28157253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy monitoring in congenital adrenal hyperplasia by dried blood samples.
    Wieacker I; Peter M; Borucki K; Empting S; Roehl FW; Mohnike K
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):867-71. PubMed ID: 25781526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of estrone sulfate, testosterone, androstenedione, DHEAS, cortisol, cortisone, and 17α-hydroxyprogesterone by LC-MS/MS in children and adolescents.
    Ankarberg-Lindgren C; Andersson MX; Dahlgren J
    Scand J Clin Lab Invest; 2020 Dec; 80(8):672-680. PubMed ID: 33258387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous quantification of 17α-OH progesterone, 11-deoxycortisol, Δ4-androstenedione, cortisol and cortisone in newborn blood spots using liquid chromatography-tandem mass spectrometry.
    Magnisali P; Chalioti MB; Livadara T; Mataragas M; Paliatsiou S; Malamitsi-Puchner A; Moutsatsou P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(19):1565-72. PubMed ID: 21514253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary testosterone may not serve as a screening test in the diagnosis of biochemical hyperandrogenism.
    Ambroziak U; Kuryłowicz A; Kępczyńska-Nyk A; Kondracka A; Gajda S; Sieńko D
    J Obstet Gynaecol Res; 2018 Jun; 44(6):1118-1125. PubMed ID: 29517119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.
    Janzen N; Peter M; Sander S; Steuerwald U; Terhardt M; Holtkamp U; Sander J
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2581-9. PubMed ID: 17456574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superior discriminating value of ACTH-stimulated serum 21-deoxycortisol in identifying heterozygote carriers for 21-hydroxylase deficiency.
    Costa-Barbosa FA; Tonetto-Fernandes VF; Carvalho VM; Nakamura OH; Moura V; Bachega TA; Vieira JG; Kater CE
    Clin Endocrinol (Oxf); 2010 Dec; 73(6):700-6. PubMed ID: 20846292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid chromatography-tandem mass spectrometric method for determination of salivary 17alpha-hydroxyprogesterone: a noninvasive tool for evaluating efficacy of hormone replacement therapy in congenital adrenal hyperplasia.
    Shibayama Y; Higashi T; Shimada K; Kashimada K; Onishi T; Ono M; Miyai K; Mizutani S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 May; 867(1):49-56. PubMed ID: 18378505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.